Literature DB >> 30555215

Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights.

Ashley L Buchanan1, Michael G Hudgens2, Stephen R Cole3, Katie R Mollan4, Paul E Sax5, Eric S Daar6, Adaora A Adimora4, Joseph J Eron4, Michael J Mugavero7.   

Abstract

Results obtained in randomized trials may not easily generalize to target populations. Whereas in randomized trials the treatment assignment mechanism is known, the sampling mechanism by which individuals are selected to participate in the trial is typically not known and assuming random sampling from the target population is often dubious. We consider an inverse probability of sampling weighted (IPSW) estimator for generalizing trial results to a target population. The IPSW estimator is shown to be consistent and asymptotically normal. A consistent sandwich-type variance estimator is derived and simulation results are presented comparing the IPSW estimator to a previously proposed stratified estimator. The methods are then utilized to generalize results from two randomized trials of HIV treatment to all people living with HIV in the United States.

Entities:  

Keywords:  Causal inference; External validity/Generalizability; HIV/AIDS; Inverse probability weights; Randomized controlled trial; Target population

Year:  2018        PMID: 30555215      PMCID: PMC6289264          DOI: 10.1111/rssa.12357

Source DB:  PubMed          Journal:  J R Stat Soc Ser A Stat Soc        ISSN: 0964-1998            Impact factor:   2.483


  17 in total

1.  Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study.

Authors:  Jared K Lunceford; Marie Davidian
Journal:  Stat Med       Date:  2004-10-15       Impact factor: 2.373

Review 2.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Estimating exposure effects by modelling the expectation of exposure conditional on confounders.

Authors:  J M Robins; S D Mark; W K Newey
Journal:  Biometrics       Date:  1992-06       Impact factor: 2.571

4.  Invited commentary: positivity in practice.

Authors:  Daniel Westreich; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2010-02-05       Impact factor: 4.897

Review 5.  Review of inverse probability weighting for dealing with missing data.

Authors:  Shaun R Seaman; Ian R White
Journal:  Stat Methods Med Res       Date:  2011-01-10       Impact factor: 3.021

6.  Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial.

Authors:  Stephen R Cole; Elizabeth A Stuart
Journal:  Am J Epidemiol       Date:  2010-06-14       Impact factor: 4.897

7.  Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols.

Authors:  Monica Gandhi; Niloufar Ameli; Peter Bacchetti; Gerald B Sharp; Audrey L French; Mary Young; Stephen J Gange; Kathryn Anastos; Susan Holman; Alexandra Levine; Ruth M Greenblatt
Journal:  AIDS       Date:  2005-11-04       Impact factor: 4.177

8.  Propensity score estimation: neural networks, support vector machines, decision trees (CART), and meta-classifiers as alternatives to logistic regression.

Authors:  Daniel Westreich; Justin Lessler; Michele Jonsson Funk
Journal:  J Clin Epidemiol       Date:  2010-08       Impact factor: 6.437

9.  Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

Authors:  Paul E Sax; Camlin Tierney; Ann C Collier; Margaret A Fischl; Katie Mollan; Lynne Peeples; Catherine Godfrey; Nasreen C Jahed; Laurie Myers; David Katzenstein; Awny Farajallah; James F Rooney; Belinda Ha; William C Woodward; Susan L Koletar; Victoria A Johnson; P Jan Geiseler; Eric S Daar
Journal:  N Engl J Med       Date:  2009-12-01       Impact factor: 91.245

10.  Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems.

Authors:  Mari M Kitahata; Benigno Rodriguez; Richard Haubrich; Stephen Boswell; W Christopher Mathews; Michael M Lederman; William B Lober; Stephen E Van Rompaey; Heidi M Crane; Richard D Moore; Michael Bertram; James O Kahn; Michael S Saag
Journal:  Int J Epidemiol       Date:  2008-02-08       Impact factor: 7.196

View more
  23 in total

1.  New methods for generalizability and transportability: the new norm.

Authors:  Sunni L Mumford; Enrique F Schisterman
Journal:  Eur J Epidemiol       Date:  2019-06-07       Impact factor: 8.082

2.  Robustifying Trial-Derived Optimal Treatment Rules for A Target Population.

Authors:  Ying-Qi Zhao; Donglin Zeng; Catherine M Tangen; Michael L LeBlanc
Journal:  Electron J Stat       Date:  2019-04-30       Impact factor: 1.125

3.  Effect heterogeneity and variable selection for standardizing causal effects to a target population.

Authors:  Anders Huitfeldt; Sonja A Swanson; Mats J Stensrud; Etsuji Suzuki
Journal:  Eur J Epidemiol       Date:  2019-10-26       Impact factor: 8.082

4.  An outcome model approach to transporting a randomized controlled trial results to a target population.

Authors:  Benjamin A Goldstein; Matthew Phelan; Neha J Pagidipati; Rury R Holman; Michael J Pencina; Elizabeth A Stuart
Journal:  J Am Med Inform Assoc       Date:  2019-05-01       Impact factor: 4.497

5.  The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009-11.

Authors:  Catherine R Lesko; Stephen R Cole; H Irene Hall; Daniel Westreich; William C Miller; Joseph J Eron; Jianmin Li; Michael J Mugavero
Journal:  Int J Epidemiol       Date:  2016-01-15       Impact factor: 7.196

6.  Assessing exposure effects on gene expression.

Authors:  Sarah A Reifeis; Michael G Hudgens; Mete Civelek; Karen L Mohlke; Michael I Love
Journal:  Genet Epidemiol       Date:  2020-06-08       Impact factor: 2.135

7.  A Randomized Trial to Evaluate the Effects of Folic Acid and Zinc Supplementation on Male Fertility and Livebirth: Design and Baseline Characteristics.

Authors:  Enrique F Schisterman; Traci Clemons; C Matthew Peterson; Erica Johnstone; Ahmad O Hammoud; Denise Lamb; Douglas T Carrell; Neil J Perkins; Lindsey A Sjaarda; Bradley J Van Voorhis; Ginny Ryan; Karen Summers; Bruce Campbell; Jared Robins; Kayla Chaney; James L Mills; Pauline Mendola; Zhen Chen; Elizabeth A DeVilbiss; Sunni L Mumford
Journal:  Am J Epidemiol       Date:  2020-01-31       Impact factor: 4.897

8.  Generalizing the per-protocol treatment effect: The case of ACTG A5095.

Authors:  Haidong Lu; Stephen R Cole; H Irene Hall; Enrique F Schisterman; Tiffany L Breger; Jessie K Edwards; Daniel Westreich
Journal:  Clin Trials       Date:  2018-10-17       Impact factor: 2.486

9.  Rejoinder: Learning Optimal Distributionally Robust Individualized Treatment Rules.

Authors:  Weibin Mo; Zhengling Qi; Yufeng Liu
Journal:  J Am Stat Assoc       Date:  2021-04-01       Impact factor: 5.033

10.  Learning Optimal Distributionally Robust Individualized Treatment Rules.

Authors:  Weibin Mo; Zhengling Qi; Yufeng Liu
Journal:  J Am Stat Assoc       Date:  2020-09-15       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.